Research and Development
Advaxis follows up Amgen deal with Phase IIa cancer trial success
August 12, 2016 Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen
Gilead to work with Genmab on HIV targeting technology
August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody
Valeant under criminal investigation
August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation
FDA accepts Marathon’s Duchenne drug for priority review
August 11, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals
Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug
August 11, 2016 Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol
Chronos Therapetics strengthens management with two new vice presidents
August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
New senior VP, finance at Eli Lilly
August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
New Agilent expansion will ‘more than double’ nucleic acid API manufacture
August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide
Interim analysis fails to show benefits for Lilly’s abemaciclib in advanced breast cancer
August 10, 2016 Research and Development Eli Lilly, abemaciclib, breast cancer
Valeant stock rises despite weak Q2 results
August 10, 2016 Research and Development, Sales and Marketing Valeant, financial results
Biogen names haemophilia spin-off Bioverativ
August 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, bioverativ
Experimental stem cell treatment shows promise in rheumatoid arthritis
August 10, 2016 Research and Development Mesoblast, rheumatoid arthritis, stem cell treatment
Old CDF drug not recommended in initial NICE guidance due to lack of evidence
August 10, 2016 Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma
Helsinn and MEI Pharma join forces to develop leukaemia drug Pracinostat
August 9, 2016 Manufacturing and Production, Research and Development Helsinn, MEI Pharma, Pracinostat, chronic myeloid leukaemia
New therapy wins EMA orphan drug designation for ALS
August 9, 2016 Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation
